Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Clinical trial NCT06337318 · RECRUITING

Trial details

NCT number: NCT06337318
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Classic Follicular Lymphoma Follicular Lymphoma With Unusual Cytological Features

Start date: 2024-10-23
Primary completion: 2032-03-31
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.